Journal
CLINICAL NUCLEAR MEDICINE
Volume 39, Issue 7, Pages E365-E366Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0000000000000238
Keywords
PET; FDG; natalizumab; progressive multifocal leukoencephalopathy; PML